Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
IM-101 by ImmunAbs for Paroxysmal Nocturnal Hemoglobinuria: Likelihood of Approval
IM-101 is under clinical development by ImmunAbs and currently in Phase I for Paroxysmal Nocturnal Hemoglobinuria. According to GlobalData, Phase...
IM-101 by ImmunAbs for Myasthenia Gravis: Likelihood of Approval
IM-101 is under clinical development by ImmunAbs and currently in Phase I for Myasthenia Gravis. According to GlobalData, Phase I...
IM-101 by ImmunAbs for Age Related Macular Degeneration: Likelihood of Approval
IM-101 is under clinical development by ImmunAbs and currently in Phase I for Age Related Macular Degeneration. According to GlobalData,...
IM-101 by ImmunAbs for Autoimmune Disorders: Likelihood of Approval
IM-101 is under clinical development by ImmunAbs and currently in Phase I for Autoimmune Disorders. According to GlobalData, Phase I...